MDxHealth Signs Agreement with Lab 21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom

IRVINE, CA, and HERSTAL, BELGIUM – March 21, 2017 – MDxHealth SA (Euronext: MDXH.BR), today announced that it has signed a distribution agreement to make its SelectMDx™ for Prostate Cancer test available to Lab 21 Clinical Laboratory’s urology clients in the United Kingdom. Under the terms of the agreement, Lab 21 will serve as a

Visit Page

Novacyt expands distribution presence in Asia Pacific

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces that it has appointed MDL Asia Pty Ltd (“MDL” or “MDL Asia”) as its marketing and distribution partner in the Asia Pacific region, excluding Greater China. Download press release

Visit Page

Novacyt Named in Deloitte Technology Fast 500

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, has been named in the Deloitte Technology Fast 500 for Europe, Middle East and Africa. Download press release

Visit Page